Sign in
Not yet recruitingNo phase

Imaging and Spectral Analysis of the Crystalline Lens Using the "HYPERLAF" Slit Lamp

Key facts

Who runs it
Centre Hospitalier Universitaire de Saint Etienne
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
50 people, planned
Started
Oct 2026
Expected to end
30 Dec 2026
Type of study
Interventional
Treatments tested
  • Non-contact observation of the crystalline lens nucleus
Record updated
15 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patients enrolled in or eligible for a social security program
  • Age 18 or older
  • Patients with cataracts. In cases of bilateral cataracts, both eyes will be photographed and analyzed
  • Patient who has already received an instillation of 0.5% mydriaticum (tropicamide) and 10% neosynephrine (Théa Laboratories, Clermont-Ferrand, France) eye drops to dilate the pupil of the eye to be photographed (or both eyes)
  • Signature of the consent form

Who cannot take part

  • Poor or absent pupil dilation: patient with an allergy or intolerance to the eye drops used for pupil dilation; refusal of pupil dilation during the eye examination
  • Severe blepharospasm making the examination impossible
  • Pregnant or breastfeeding patient
  • person under legal guardianship

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Cataract is the leading cause of reversible blindness and the first surgery worldwide. It corresponds to the crystalline lens opacification. Nevertheless, its grading remains mostly subjective and the Lens Opacities Classification System dating back 1993, is not used in daily practice and has not been revisited since. The HYPERLAF device developed by the start-up HYPEREYE is a modified slit lamp which combines imaging and spectral analysis, providing two quantitative objective scores: OPAK (opacity) and COLOR (spectral analysis). It is a non-CE marked prototype with non-invasive imaging methods.

The group in the trial

  • Patients with cataractsTreatment being tested

    Patients will be recruited from the ophthalmology clinic at Saint-Étienne University Hospital. After a clinical diagnosis of cataracts using a slit lamp, patients will be invited to participate in the clinical trial.

    Treatment: Non-contact observation of the crystalline lens nucleus

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
15 October 2026